The biology of chronic myelogenous leukemia: implications for imatinib therapy

RH Alvarez, H Kantarjian, JE Cortes - Seminars in hematology, 2007 - Elsevier
Chronic myelogenous leukemia (CML) results from the neoplastic transformation of primitive
hematopoietic stem cells, and has been classified as a myeloproliferative disorder. The …
被引用次数：74 相关文章
[PDF] academia.edu

[PDF][PDF] The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy

RH Alvarez, H Kantarjian, JE Cortesb - Semin Hematol - academia.edu
Chronic myelogenous leukemia (CML) results from the neoplastic transformation of primitive
hematopoietic stem cells, and has been classified as a myeloproliferative disorder. The …

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy

RH Alvarez, H Kantarjian… - Seminars in …, 2007 - augusta.elsevierpure.com
Chronic myelogenous leukemia (CML) results from the neoplastic transformation of primitive
hematopoietic stem cells, and has been classified as a myeloproliferative disorder. The …

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy

RH Alvarez, H Kantarjian… - Seminars in …, 2007 - mdanderson.elsevierpure.com
Chronic myelogenous leukemia (CML) results from the neoplastic transformation of primitive
hematopoietic stem cells, and has been classified as a myeloproliferative disorder. The …

The biology of chronic myelogenous leukemia: implications for imatinib therapy.

RH Alvarez, H Kantarjian, JE Cortes - Seminars in Hematology, 2007 - europepmc.org
Chronic myelogenous leukemia (CML) results from the neoplastic transformation of primitive
hematopoietic stem cells, and has been classified as a myeloproliferative disorder. The …

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy

RH Alvarez, H Kantarjian, JE Cortes - Seminars in Hematology, 2007 - infona.pl
Chronic myelogenous leukemia (CML) results from the neoplastic transformation of primitive
hematopoietic stem cells, and has been classified as a myeloproliferative disorder. The …

The biology of chronic myelogenous leukemia: implications for imatinib therapy

RH Alvarez, H Kantarjian… - Seminars in …, 2007 - pubmed.ncbi.nlm.nih.gov
Chronic myelogenous leukemia (CML) results from the neoplastic transformation of primitive
hematopoietic stem cells, and has been classified as a myeloproliferative disorder. The …